ACADIA Pharmaceuticals
ACAD
#3690
Rank
โ‚ฌ2.64 B
Marketcap
15,93ย โ‚ฌ
Share price
-1.47%
Change (1 day)
-23.41%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): โ‚ฌ40.79 Million

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.89 Billion. In 2023 the company made an earning of -โ‚ฌ48.47 Million, an increase over its 2022 earnings that were of -โ‚ฌ0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ40.79 M-184.17%
2023 -โ‚ฌ48.47 Million-76.09%
2022 -โ‚ฌ0.21 Billion27.41%
2021 -โ‚ฌ0.16 Billion-40.38%
2020 -โ‚ฌ0.27 Billion19.88%
2019 -โ‚ฌ0.23 Billion-3.92%
2018 -โ‚ฌ0.24 Billion-15.04%
2017 -โ‚ฌ0.28 Billion6.33%
2016 -โ‚ฌ0.26 Billion64.55%
2015 -โ‚ฌ0.16 Billion77.47%
2014 -โ‚ฌ87.82 Million143.69%
2013 -โ‚ฌ36.04 Million81.93%
2012 -โ‚ฌ19.81 Million-8.73%
2011 -โ‚ฌ21.71 Million-251.39%
2010 โ‚ฌ14.33 M-133.2%
2009 -โ‚ฌ43.19 Million-30.82%
2008 -โ‚ฌ62.42 Million6.43%
2007 -โ‚ฌ58.65 Million25.89%
2006 -โ‚ฌ46.59 Million36.99%
2005 -โ‚ฌ34.01 Million37.22%
2004 -โ‚ฌ24.79 Million19.96%
2003 -โ‚ฌ20.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ30.84 Million-170.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ1.16 Billion-2,749.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.63 B 22,089.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.46 B 40,112.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.54 Billion-15,140.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ36.69 Million-184.45%๐Ÿ‡บ๐Ÿ‡ธ USA